[
  {
    "path": "posts/genometracksig/",
    "title": "GenomeTrackSig",
    "description": "Preprint",
    "author": [],
    "date": "2022-08-07",
    "categories": [
      "cancer evolution",
      "machine learning",
      "preprint"
    ],
    "contents": "\r\n\r\n\r\n\r\npaper code\r\n\r\n\r\nKey Ideas\r\nWe observe mutational signature activity to vary on a large scale across the genome.\r\nChromatin changes over the course of tumour evolution may be shared across many tumours of the same tissue type. In particular: Melanoma, CLL.\r\nCitation\r\nCaitlin Timmons, Quaid Morris, and Caitlin F. Harrigan, “Regional Mutational Signature Activities in Cancer Genomes,” bioRxiv [preprint], Jan. 2022, doi: 10.1101/2022.01.23.477261.\r\n\r\n\r\n\r\n",
    "preview": "posts/genometracksig/preview.jpg",
    "last_modified": "2022-07-08T23:27:57-04:00",
    "input_file": {}
  },
  {
    "path": "posts/mtor-rcc/",
    "title": "Oncogenic mTOR mutations are detrimental in nutrient-poor conditions",
    "description": "In: Cancer Research 2022",
    "author": [],
    "date": "2022-01-09",
    "categories": [
      "driver mutations",
      "oncogenesis",
      "peer reviewed"
    ],
    "contents": "\r\n\r\n\r\n\r\npaper code\r\n\r\n\r\nKey Ideas\r\nMany cancers lack activating mTOR mutations, but this is not the case in Renal Clear Cell Carcinoma (RCCC)\r\nmTOR is involved in several important pathways: including growth, and nutrient sensing\r\nIn nutrient-rich conditions (such as in hypervascular kidney tissue), disregulated mTOR may be less detrimental for survival than in nutrient-poor conditions, accounting for the enrichment mTOR mutations in RCCC.\r\nCitation\r\nTODO\r\n\r\n\r\n\r\n",
    "preview": "posts/mtor-rcc/preview.jpg",
    "last_modified": "2022-07-09T14:08:47-04:00",
    "input_file": {}
  },
  {
    "path": "posts/consider-uncertainty/",
    "title": "Considerations for Visualizing Uncertainty",
    "description": "Workshop paper presented at CHI 2021",
    "author": [],
    "date": "2021-05-01",
    "categories": [
      "data viz",
      "clinical ml"
    ],
    "contents": "\r\n\r\n\r\n\r\npaper\r\n\r\nKey Ideas\r\nDisplaying uncertainty when visualizing a model output increases trust in the prediction\r\nClinicians are a unique user group because they interpret predictions by examining raw features alongside model output\r\nCitation\r\nCaitlin F Harrigan*, Gabriella Morgenshtern*, Anna Goldenberg, and Fanny Chevalier. “Considerations for Visualizing Uncertainty in Clinical Machine Learning Models”. Workshop: Realizing AI in Healthcare: Challenges Appearing in the Wild, CHI 2021 Online Virtual Conference (originally Yokohama, Japan), May. 2021.\r\n* Equal contribution\r\n\r\n\r\n\r\n",
    "preview": "posts/consider-uncertainty/preview.png",
    "last_modified": "2022-07-08T22:43:19-04:00",
    "input_file": {},
    "preview_width": 1491,
    "preview_height": 541
  },
  {
    "path": "posts/tracksigfreq/",
    "title": "TrackSigFreq",
    "description": "In: Proceedings of the Pacific Symposium on Biocomputing, January 2020",
    "author": [],
    "date": "2020-03-02",
    "categories": [
      "cancer evolution",
      "machine learning",
      "peer reviewed"
    ],
    "contents": "\r\n\r\n\r\n\r\npaper code\r\n\r\n\r\nKey Ideas\r\nBoth variant allele frequency (VAF) and mutational signatures are useful for identifying subclonal cell populations\r\nTrackSig is easily extensible to account for VAF when detecting subclonal evolution\r\nCitation\r\nCaitlin F Harrigan, Yulia Rubanova, Quaid Morris, and Alina Selega. “TrackSigFreq : subclonal reconstructions based on mutation signatures and allele frequencies”. In: Pacific Symposium on Biocomputing 25 (2020), pp. 238-249.\r\n\r\n\r\n\r\n",
    "preview": "posts/tracksigfreq/preview.png",
    "last_modified": "2022-07-08T22:43:19-04:00",
    "input_file": {},
    "preview_width": 850,
    "preview_height": 488
  },
  {
    "path": "posts/tracksig/",
    "title": "TrackSig",
    "description": "In: Nature Communications, February 2020",
    "author": [],
    "date": "2020-02-27",
    "categories": [
      "cancer evolution",
      "machine learning",
      "peer reviewed"
    ],
    "contents": "\r\n\r\n\r\n\r\npaper code\r\n\r\n\r\nKey Ideas\r\nOrder mutations by pseudotime: every cell contains all the mutations of its ancestors\r\nSubclonal evolution can be observed by detecting changes in mutational processes\r\nCitation\r\nYulia Rubanova, Ruian Shi, Caitlin F Harrigan, Roujia Li, Jeff Wintersinger, Nil Sahin, Amit Deshwar, and Quaid Morris. “Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig”. En. In: Nature Communications 11.1 (Feb. 2020). Number: 1 Publisher: Nature Publishing Group, pp. 1-12.\r\n\r\n\r\n\r\n",
    "preview": "posts/tracksig/preview.png",
    "last_modified": "2022-07-08T22:43:19-04:00",
    "input_file": {},
    "preview_width": 1612,
    "preview_height": 636
  }
]
